(Q36920613)

17 August 2017

1 reference

title

Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised? (English)

1 reference

17 August 2017

1 reference

David S H Bell

1

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

67

1 reference

17 August 2017

issue

13

1 reference

17 August 2017

page(s)

1813-1827

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767130-00002

17 August 2017

exact match

0 references

cites work

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

12 December 2020

Therapeutic approaches to preserve islet mass in type 2 diabetes

1 reference

12 December 2020

Treatment of type 2 diabetes. The addition of injection therapy

1 reference

12 December 2020

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

1 reference

12 December 2020

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

12 December 2020

Diabetic control after total pancreatectomy

1 reference

12 December 2020

1 reference

12 December 2020

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

12 December 2020

Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes

1 reference

12 December 2020

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

1 reference

12 December 2020

Insulin glulisine. Aventis Pharma.

1 reference

12 December 2020

Insulin analogues and their potential in the management of diabetes mellitus

1 reference

12 December 2020

The role of C-peptide levels in screening for latent autoimmune diabetes in adults

1 reference

12 December 2020

Refractive changes in diabetic patients during intensive glycaemic control

1 reference

12 December 2020

Spotlight on insulin glargine in type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Weight gain and insulin treatment

1 reference

12 December 2020

A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

1 reference

12 December 2020

Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects

1 reference

12 December 2020

Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups

1 reference

12 December 2020

Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs

1 reference

12 December 2020

Frequency of severe hypoglycemia in patients with non-insulin-dependent diabetes mellitus treated with sulfonylureas or insulin

1 reference

12 December 2020

Reduced insulin clearance in normal subjects due to extreme hyperinsulinemia

1 reference

12 December 2020

Premixed insulin analogues for the treatment of diabetes mellitus

1 reference

12 December 2020

Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart

1 reference

12 December 2020

From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes

1 reference

12 December 2020

C-Peptide utilization in clinical practice: effect on treatment and outcome of diabetes in a series of cases

1 reference

12 December 2020

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes

1 reference

12 December 2020

Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women

1 reference

12 December 2020

Reproducibility and variability in the action of injected insulin

1 reference

12 December 2020

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times

1 reference

12 December 2020

Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.

1 reference

12 December 2020

Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

1 reference

12 December 2020

Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms

1 reference

12 December 2020

Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Dosage accuracy of self-mixed vs premixed insulin

1 reference

12 December 2020

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

12 December 2020

Insulin absorption: a major factor in apparent insulin resistance and the control of type 2 diabetes mellitus.

1 reference

12 December 2020

Narrative review: a rational approach to starting insulin therapy

1 reference

12 December 2020

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

12 December 2020

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study

1 reference

12 December 2020

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy

1 reference

12 December 2020

Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes

1 reference

12 December 2020

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial

1 reference

12 December 2020

Efficacy of biphasic insulin aspart in patients with type 2 diabetes

1 reference

12 December 2020

The pathophysiological basis for intensive insulin replacement

1 reference

12 December 2020

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

12 December 2020

Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens

1 reference

12 December 2020

Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes

1 reference

12 December 2020

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

12 December 2020

Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.

1 reference

12 December 2020

10.2165/00003495-200767130-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1004456235

0 references

1 reference